Cáncer Pulmonar de Célula No Pequeña


A controlled Study of Postoperative Radiotherapy for Patients with Completey Resected Non-Small Cell Lung Carcinoma
Chemoradiation for Locally Advanced, Unresectable NSCLC-New Standard of Care, Emerging Strategies
Molecular Pathological Substaging in 244 Stage I Non-Small Cell Lung Cancer Patients: Clinical Implications
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
Patterns of Failure after Resection of Non-small-cell lung cancer: Implications for Postoperative Radiation Therapy Volumes
Phase III Study of Concurrent versus Sequential Thoracic Radiotherapy in Combination with Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non-Small-Cell Lung cancer
Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials
Preoperative Chemotherapy Followed by Concurrent Chemoradiation Therapy Based Hyperfractionated Accelerated Radiotherapy and Definitive Surgery in Locally Advanced Non-Small Cell LungCancer: Mature Results of a Phase II Trial
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non?Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Radiosensitization with Carboplatin for Patients with Unresectable Stage III Non-Small-Cell Lung Cancer: A phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non?Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
Toxicity and Outcome Results of RTOG 93-11: A Phase I-II Dose-Escalation Study Using Three-Dimensional Conformal Radiotherapy in Patients with Inoperable Non-small-cell Lung Carcinoma
English
News
Appears to increase risk after liver transplant in younger patients, those with C2 monitoring

Jul 1, 2010 - Immunosuppressive treatment with cyclosporine A, rather than tacrolimus, with dose level monitoring two hours post-dosing or in patients age 50 or younger appears to have a significant association with the development of de novo cancer after liver transplantation, according to research published in the July issue of Liver Transplantation.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información